Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E146.67 EPS (ttm)0.07 Insider Own3.00% Shs Outstand111.49M Perf Week2.22%
Market Cap1.13B Forward P/E25.11 EPS next Y0.40 Insider Trans-66.97% Shs Float98.73M Perf Month16.99%
Income8.10M PEG- EPS next Q0.03 Inst Own57.70% Short Float5.84% Perf Quarter27.62%
Sales81.30M P/S13.88 EPS this Y216.90% Inst Trans4.32% Short Ratio7.71 Perf Half Y55.93%
Book/sh0.37 P/B27.35 EPS next Y58.04% ROA13.50% Target Price10.75 Perf Year135.90%
Cash/sh0.46 P/C21.91 EPS next 5Y- ROE27.50% 52W Range4.09 - 11.40 Perf YTD39.39%
Dividend- P/FCF61.99 EPS past 5Y16.90% ROI18.10% 52W High-11.23% Beta1.80
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin97.50% 52W Low147.43% ATR0.49
Employees103 Current Ratio2.40 Sales Q/Q58.70% Oper. Margin12.50% RSI (14)59.28 Volatility4.70% 5.52%
OptionableYes Debt/Eq0.36 EPS Q/Q339.70% Profit Margin10.00% Rel Volume0.80 Prev Close9.99
ShortableYes LT Debt/Eq0.00 EarningsMar 01 AMC Payout0.00% Avg Volume748.24K Price10.12
Recom3.00 SMA203.41% SMA5017.17% SMA20040.88% Volume597,845 Change1.30%
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Mar-20-17 03:03PM  Corcept Therapeutices Eyes Another Double
Mar-17-17 09:30AM  Today's Research Reports on Stocks to Watch: Array Biopharma and Corcept Therapeutics Accesswire
Mar-10-17 04:39PM  Under-The-Radar Biotech Tests Buy Zone; Cancer Trial Results 'Encouraging' +9.25%
01:04PM  CORCEPT THERAPEUTICS INC Financials
Mar-07-17 12:15PM  Corcept Therapeutics, Inc. :CORT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
Mar-06-17 08:44AM  Corcept beats 4Q profit forecasts
08:37AM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure
08:30AM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance Marketwired
Feb-14-17 01:56PM  Corcept Therapeutics, Inc. Value Analysis (NASDAQ:CORT) : February 14, 2017
Feb-13-17 04:19PM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi
Feb-02-17 07:23AM  Coverage initiated on Corcept Therapeutics by Ladenburg Thalmann
Jan-31-17 02:14AM  Edited Transcript of CORT earnings conference call or presentation 30-Jan-17 10:00pm GMT
Jan-30-17 04:05PM  Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance Marketwired
07:07AM  Preliminary Q4 2016 Corcept Therapeutics Inc Earnings Release - After Market Close
Jan-23-17 04:05PM  Corcept Therapeutics to Announce Preliminary 2016 Financial Results, Provide 2017 Revenue Guidance and Corporate Update, and Host Conference Call Marketwired
Jan-11-17 07:26AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CORT-US : January 11, 2017
Jan-09-17 07:25AM  3 Stocks Expected to More Than Double Their Earnings in 2017 at Motley Fool
Dec-23-16 09:23AM  Corcept Therapeutics, Inc. Value Analysis (NASDAQ:CORT) : December 23, 2016
Dec-22-16 07:26AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : December 22, 2016
Dec-12-16 09:54AM  Corcept Korlym Positive in Phase I/II Breast Cancer Study
Dec-10-16 09:37PM  Should You Add Corcept Therapeutics Incorporated (CORT) To Your Portfolio? at Insider Monkey
08:30AM  Corcept Therapeutics Announces Encouraging Results of Phase 1/2 Trial of Mifepristone Plus Eribulin in Triple-Negative Breast Cancer Marketwired
Nov-11-16 08:35AM  Corcept (CORT) Looks Good: Stock Jumps 6.5% in Session +9.71%
Nov-02-16 08:12AM  Corcept (CORT) Beats on Q3 Earnings, Lifts Sales Guidance +8.53%
06:08AM  CORCEPT THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
05:02AM  Edited Transcript of CORT earnings conference call or presentation 1-Nov-16 9:00pm GMT
Nov-01-16 05:40PM  Corcept beats 3Q profit forecasts
04:11PM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure
04:05PM  Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update Marketwired
07:07AM  Q3 2016 Corcept Therapeutics Inc Earnings Release - After Market Close
Oct-26-16 08:30AM  Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call Marketwired
Sep-29-16 02:13PM  Top 3 Growth Stocks Under $10
Sep-27-16 10:12AM  Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
10:01AM  PAREXEL International (PRXL) Set to Acquire ExecuPharm
09:42AM  Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep-26-16 09:18AM  Novartis Ilaris Approved for Extended Use in Periodic Fever
08:56AM  Glaxo/J&J File BLA for Rheumatoid Arthritis Drug in the U.S.
Sep-22-16 10:55AM  ETFs with exposure to Corcept Therapeutics, Inc. : September 22, 2016
09:30AM  Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife highlighted as Zacks Bull and Bear of the Day
Sep-21-16 03:20PM  Here are 2 Momentous Healthcare Stocks to Buy Now
10:28AM  Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
08:45AM  Aldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7%
08:37AM  New Strong Buy Stocks for September 21st
Sep-19-16 10:25AM  Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
10:16AM  Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep-14-16 08:39AM  Should You Get Rid of Forward Pharma (FWP) Now?
08:00AM  Nivalis Therapeutics (NVLS) Catches Eye: Stock Jumps 5.8%
Sep-12-16 09:06AM  4 Growth Stocks at Low Prices to Counter the Market Slump
Sep-09-16 01:56PM  Corcept Therapeutics, Inc. Value Analysis (NASDAQ:CORT) : September 9, 2016
Sep-08-16 09:21AM  5 Stocks Under $10 That Could Make You a Lot of Money
08:07AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CORT-US : September 8, 2016
Sep-07-16 10:59AM  Bristol-Myers' Orencia Gains EU Approval for Expanded Use
10:58AM  Karyopharm Reports Positive Multiple Myeloma Study Data
10:58AM  BioMarin's (BMRN) Brineura Review Period Extended by FDA
Sep-06-16 09:30AM  Zacks.com featured highlights: Corcept Therapeutics, Parsley Energy, TRI Pointe Group, NuVasive and Facebook
Sep-02-16 07:26AM  Bet on These 5 Profitable Stocks for Big Returns
Aug-29-16 08:41AM  Roche Gets FDA Nod for Emergency Use of Zika Virus Test
Aug-24-16 05:02PM  Cempra's Application for Pneumonia Drug Validated in EU
Aug-23-16 10:02AM  Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug-22-16 11:16AM  ETFs with exposure to Corcept Therapeutics, Inc. : August 22, 2016
09:52AM  Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
08:43AM  What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Aug-19-16 10:22AM  Horizon (HZNP) Rayos Receives USPTO Notice of Allowance
08:20AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : August 19, 2016
Aug-16-16 04:48PM  Endo (ENDP) Withdraws Label Expansion Filing for Opana ER
Aug-15-16 09:26AM  Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Aug-12-16 12:24PM  Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
Aug-11-16 12:39PM  ETFs with exposure to Corcept Therapeutics, Inc. : August 11, 2016
09:31AM  Adverum (ADVM) Reports Narrower-than-Expected Q2 Loss
Aug-10-16 02:57PM  GW Pharma (GWPH) Incurs Narrower-than-Expected Q3 Loss -6.12%
11:58AM  Corcept Therapeutics, Inc. :CORT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
10:49AM  Perrigo (PRGO) Misses Q2 Earnings Estimates, Cuts '16 View
Aug-09-16 09:06AM  Why Corcept Therapeutics (CORT) Could Be a Potential Winner
Aug-08-16 09:30AM  Zacks.com featured highlights: Logitech International SA, A10 Networks, TriNet Group, Corcept Therapeutics and Antero Resources
08:25AM  Egalet (EGLT) Catches Eye: Stock Adds 6.8% in Session
Aug-05-16 03:49PM  ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4
10:23AM  5 Liquid Stocks for a Steady Flow of High Returns
Aug-03-16 10:31AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : August 3, 2016 +5.77%
06:07AM  CORCEPT THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
02:52AM  Edited Transcript of CORT earnings conference call or presentation 2-Aug-16 9:00pm GMT
Aug-02-16 05:08PM  Corcept beats 2Q profit forecasts
04:25PM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:05PM  Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update Marketwired
07:07AM  Q2 2016 Corcept Therapeutics Inc Earnings Release - After Market Close
Jul-26-16 04:05PM  Corcept Therapeutics to Announce Second Quarter 2016 Financial Results and Corporate Update and Host Conference Call Marketwired
Jul-14-16 12:22PM  Everybody's Doing It: 5 Stocks Under $10 That I Like
Jun-29-16 09:30AM  Zacks.com featured highlights: Arcos Dorados Holdings, Corcept Therapeutics, Exelixis, Hecla Mining and Lexington Realty Trust
Jun-28-16 04:39PM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
04:05PM  Corcept Therapeutics Appoints Renee D. Gala to Board of Directors Marketwired
03:27PM  Explosive Stocks Under $10
Jun-27-16 10:28AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : June 27, 2016
Jun-03-16 05:06PM  Corcept (CORT) Reports Early Breast Cancer Data on Korlym -6.88%
Jun-02-16 04:05PM  Corcept Therapeutics Provides Update of Progress in Cortisol Modulation Oncology Program Marketwired
May-19-16 04:16PM  CORCEPT THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-12-16 03:29PM  ETFs with exposure to Corcept Therapeutics, Inc. : May 12, 2016
May-10-16 12:06PM  Corcept Therapeutics, Inc. :CORT-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 03:04PM  Corcept (CORT) Posts In-Line Q1 Earnings, Korlym in Focus
01:53PM  CORCEPT THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
May-03-16 09:39PM  Edited Transcript of CORT earnings conference call or presentation 3-May-16 9:00pm GMT
04:35PM  Corcept beats 1Q profit forecasts
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer. In addition, it develops CORT125134 for the treatment of patients with Cushing's syndrome and solid-tumor cancers; and CLIA-validated assay to measure expression of the gene FKBP5, which is stimulated by cortisol activity at glucocorticoid receptor. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ENRIGHT PATRICK GDirectorMar 16Sale9.94269,9552,683,237114,675Mar 20 04:36 PM
ENRIGHT PATRICK GDirectorMar 15Sale10.24279,0202,856,766139,630Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 14Sale10.01300,0003,002,670145,113Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 13Sale11.1320,980233,491151,008Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 08Sale9.75750,0007,312,500151,420Mar 10 04:22 PM
ENRIGHT PATRICK GDirectorFeb 27Sale9.051,000,0009,050,000166,157Feb 27 07:04 PM
ENRIGHT PATRICK GDirectorFeb 23Sale8.651,500,00012,975,000185,807Feb 27 07:04 PM
Longitude Venture Partners L.P10% OwnerNov 25Sale9.392902,722180,103Nov 25 09:08 PM
Longitude Venture Partners L.P10% OwnerNov 25Sale9.3914,451135,65013,775,899Nov 25 09:08 PM
ENRIGHT PATRICK GDirectorNov 25Sale9.3914,741138,372180,103Nov 25 09:05 PM
Longitude Venture Partners L.P10% OwnerNov 23Sale9.302482,307180,393Nov 25 09:08 PM
Longitude Venture Partners L.P10% OwnerNov 23Sale9.3012,352114,92113,790,350Nov 25 09:08 PM
ENRIGHT PATRICK GDirectorNov 23Sale9.3012,600117,228180,393Nov 25 09:05 PM
Longitude Venture Partners L.P10% OwnerNov 22Sale9.331891,763180,641Nov 25 09:08 PM
Longitude Venture Partners L.P10% OwnerNov 22Sale9.339,41187,80213,802,702Nov 25 09:08 PM
ENRIGHT PATRICK GDirectorNov 22Sale9.339,60089,565180,641Nov 25 09:05 PM
ENRIGHT PATRICK GDirectorNov 21Sale9.39118,3851,111,162180,830Nov 21 09:02 PM
Longitude Venture Partners L.P10% OwnerNov 21Sale9.392,32721,841180,830Nov 21 09:10 PM
Longitude Venture Partners L.P10% OwnerNov 21Sale9.39116,0581,089,32013,812,113Nov 21 09:10 PM
ENRIGHT PATRICK GDirectorNov 18Sale9.47100,562952,684183,157Nov 21 09:02 PM
Longitude Venture Partners L.P10% OwnerNov 18Sale9.471,97618,720183,157Nov 21 09:10 PM
Longitude Venture Partners L.P10% OwnerNov 18Sale9.4798,586933,96413,928,171Nov 21 09:10 PM
ENRIGHT PATRICK GDirectorNov 17Sale9.64325,1533,135,580185,133Nov 21 09:02 PM
Longitude Venture Partners L.P10% OwnerNov 17Sale9.64318,7643,073,96914,026,757Nov 21 09:10 PM
ENRIGHT PATRICK GDirectorNov 16Sale9.5117,394165,394191,522Nov 17 04:36 PM
ENRIGHT PATRICK GDirectorNov 15Sale9.55157,4531,504,211191,864Nov 17 04:36 PM
WILSON JAMES NDirectorNov 11Option Exercise1.5114,21621,466915,283Nov 14 07:40 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 11Option Exercise1.50200,000300,0002,364,195Nov 14 07:43 PM
MAHONEY DAVID LDirectorNov 11Option Exercise2.7030,00081,0001,199,320Nov 14 08:02 PM
MAHONEY DAVID LDirectorNov 11Sale9.3530,000280,5001,169,320Nov 14 08:02 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 11Sale9.10200,0001,820,3002,164,195Nov 14 07:43 PM
WILSON JAMES NDirectorNov 11Sale9.1014,216129,387901,067Nov 14 07:40 PM
WILSON JAMES NDirectorNov 10Option Exercise1.5133,24750,203934,314Nov 14 07:40 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 10Option Exercise1.50300,000450,0002,464,195Nov 14 07:43 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 10Sale8.90300,0002,670,4502,164,195Nov 14 07:43 PM
WILSON JAMES NDirectorNov 10Sale8.9033,247295,948901,067Nov 14 07:40 PM
WILSON JAMES NDirectorNov 09Option Exercise1.51111,349168,1371,012,416Nov 14 07:40 PM
WILSON JAMES NDirectorNov 09Sale8.32111,349926,914901,067Nov 14 07:40 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 07Option Exercise1.50500,000750,0002,570,662Nov 09 08:29 PM
BELANOFF JOSEPH KCHIEF EXECUTIVE OFFICERNov 07Sale8.31500,0004,152,5472,164,195Nov 09 08:29 PM
BAKER G LEONARD JRDirectorMay 10Buy5.0029,498147,629776,838May 10 06:59 PM
BAKER G LEONARD JRDirectorMay 09Buy4.8826,302128,380747,340May 10 06:59 PM
BAKER G LEONARD JRDirectorMay 06Buy4.7944,200211,886721,038May 10 06:59 PM